SAN FRANCISCO, Jan. 2, 2025 /PRNewswire/ — Fapon Biopharma, an innovator in developing therapeutic antibodies and fusion proteins, will present its latest breakthrough immunocytokine, FP008, on Jan 14, 2025, at the Biotech Showcase investor conference, following J.P. Morgan Healthcare Week. This bifunctional anti-PD-1/IL-10M fusion protein is designed to address populations refractory to anti-PD-1 therapies. The presentation… Continue reading Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers
Tag: Morgan
Sentry completes acquisition of The General® from American Family Insurance
STEVENS POINT, Wis. and NASHVILLE, Tenn., Jan. 1, 2025 /PRNewswire/ — Sentry Insurance, one of the nation’s top mutual insurance companies, today announced the successful completion of its acquisition of The General®, a leading provider of non-standard auto (NSA) insurance, from American Family Insurance. The $1.7 billion transaction, first announced in September, represents the largest… Continue reading Sentry completes acquisition of The General® from American Family Insurance
Emergency Medical Services for Children Reauthorization Act Signed into Law by President
Legislation will ensure funding for state-of-the-art pediatric-specific equipment and resources in EDs SCHAUMBURG, Ill., Dec. 31, 2024 /PRNewswire/ — Championed by ENA for many years, and a key legislative priority for the association in 2024, the Emergency Medical Services for Children program will continue to support emergency departments after President Biden signed the bill reauthorizing EMSC’s… Continue reading Emergency Medical Services for Children Reauthorization Act Signed into Law by President
AYPA POWER SECURES $190 MILLION FINANCING FOR THE BYPASS BATTERY STORAGE PROJECT IN TEXAS
AUSTIN, Texas, Dec. 31, 2024 /PRNewswire/ – Aypa Power, a Blackstone portfolio company and a leading developer and operator of utility-scale energy storage and hybrid renewable energy projects, successfully closed a $190 million financing package for the Bypass Battery Energy Storage System (BESS) project. Located in Fort Bend County, Texas, near Houston, the 200 MW /… Continue reading AYPA POWER SECURES $190 MILLION FINANCING FOR THE BYPASS BATTERY STORAGE PROJECT IN TEXAS
Anterix Announces Tom Kuhn as Chairman of the Board of Directors as Morgan O’Brien Retires After More Than 12 Years on the Board
WOODLAND PARK, N.J., Dec. 30, 2024 /PRNewswire/ — Anterix (NASDAQ: ATEX) (“the Company”) announced today utility industry veteran Tom Kuhn as Chairman of the Anterix Board of Directors, effective January 1st, as the end of 2024 marks the anticipated retirement of Morgan O’Brien as Executive Chairman of the Anterix Board after more than 12 years… Continue reading Anterix Announces Tom Kuhn as Chairman of the Board of Directors as Morgan O’Brien Retires After More Than 12 Years on the Board
Plume Network Taps Ondo Finance to Broaden RWAfi Ecosystem with Tokenized US Treasuries
NEW YORK, Dec. 30, 2024 /PRNewswire/ — Ondo Finance, renowned for its institutional-grade financial products on the blockchain, and Plume Network, the first fully integrated and modular layer-1 blockchain designed for Real World Asset Finance (RWAfi), are excited to announce plans to expand the use cases of RWAfi by natively issuing Ondo’s Tokenized US Treasuries… Continue reading Plume Network Taps Ondo Finance to Broaden RWAfi Ecosystem with Tokenized US Treasuries
Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SEONGNAM, South Korea and BOSTON, Dec. 30, 2024 /PRNewswire/ — Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis and cancer, today announced that James Jungkue Lee, Founder and CEO of Bridge Biotherapeutics, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025. Location: Georgian Room… Continue reading Bridge Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression
Aiming to be the first FDA-approved medication to treat suicidal depression Designed to help address the needs of the more than 13 million Americans who seriously consider suicide each year (CDC) Completion of NDA filing expected in the first quarter of 2025 Company to participate in 1×1 meetings in San Francisco during the Annual J.P.… Continue reading NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression
Can Biden’s green boom survive Trump’s wrecking ball?
Some things, like electric vehicle customer tax credits and offshore wind-power support, look doomed. The same goes for regulatory struts, such as tighter fuel economy standards. The energy transition sustained an electoral trauma as 2024 drew to a close. The incoming administration of President-elect Donald Trump promises to undo at least some of the progress… Continue reading Can Biden’s green boom survive Trump’s wrecking ball?
FSK Completes Public Offering of $100 million 6.125% Unsecured Notes Due 2030
PHILADELPHIA and NEW YORK, Dec. 27, 2024 /PRNewswire/ — FS KKR Capital Corp. (NYSE: FSK) today announced that it has completed its previously announced offering of an additional $100 million in aggregate principal amount of its 6.125% notes due 2030 (the “Notes”). The Notes will be a further issuance of, and form a single series… Continue reading FSK Completes Public Offering of $100 million 6.125% Unsecured Notes Due 2030